Literature DB >> 26410634

Predicting Blood Loss in Total Knee and Hip Arthroplasty.

Stephen C Sizer1, Jeffrey J Cherian1, Randa D K Elmallah1, Todd P Pierce1, Walter B Beaver2, Michael A Mont3.   

Abstract

Marked blood loss during lower extremity total joint arthroplasties may lead to higher rates of transfusion, which may negatively affect surgical outcomes and yield greater complication rates. It is therefore ideal to identify factors that may increase the likelihood of blood loss, so they can be modified. From this review, it can be concluded that preoperative anemia, older age, multiple comorbidities, increased operative time, and use of postoperative anticoagulation may lead to higher blood loss and transfusion rates, although the influence of other factors remains controversial.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood loss; Total hip arthroplasty; Total knee arthroplasty; Tranexamic acid; Transfusion risk

Mesh:

Substances:

Year:  2015        PMID: 26410634     DOI: 10.1016/j.ocl.2015.06.002

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  18 in total

Review 1.  Review article: Patient characteristics that act as risk factors for intraoperative complications in hip, knee, and shoulder arthroplasties.

Authors:  Adel Hijazi; Muhammad Talha Padela; Zain Sayeed; Aws Hammad; Kamela Devole; Todd Frush; Gamal Mostafa; Walid K Yassir; Khaled J Saleh
Journal:  J Orthop       Date:  2019-06-17

Review 2.  The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Yan Zhao; Chao Jiang; Huiming Peng; Bin Feng; Yulong Li; Xisheng Weng
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  The combined effect of administration of intravenous and topical tranexamic acid on blood loss and transfusion rate in total knee arthroplasty: Combined tranexamic acid for TKA.

Authors:  Z F Yuan; H Yin; W P Ma; D L Xing
Journal:  Bone Joint Res       Date:  2016-08       Impact factor: 5.853

4.  Risk of pneumonia and urinary tract infection within the first week after total hip arthroplasty and the impact on survival.

Authors:  Eva N Glassou; Torben B Hansen; Alma B Pedersen
Journal:  Clin Epidemiol       Date:  2017-01-23       Impact factor: 4.790

5.  Predicting Factors for Allogeneic Blood Transfusion and Excessive Postoperative Blood Loss after Single Low-Dosage Intra-Articular Tranexamic Acid Application in Total Knee Replacement.

Authors:  Paphon Sa-Ngasoongsong; Siwadol Wongsak; Noratep Kulachote; Pongsthorn Chanplakorn; Patarawan Woratanarat; Viroj Kawinwonggowit
Journal:  Biomed Res Int       Date:  2017-02-26       Impact factor: 3.411

6.  The efficacy of intravenous aminocaproic acid in primary total hip and knee arthroplasty: a meta-analysis.

Authors:  Yong-Jiang Li; Bi-Sheng Xu; Sun-Peng Bai; Xiao-Jun Guo; Xiang-Yuan Yan
Journal:  J Orthop Surg Res       Date:  2018-04-17       Impact factor: 2.359

7.  Factors associated with the length of stay in total knee arthroplasty patients with the enhanced recovery after surgery model.

Authors:  Guoqing Li; Jian Weng; Chang Xu; Deli Wang; Ao Xiong; Hui Zeng
Journal:  J Orthop Surg Res       Date:  2019-11-06       Impact factor: 2.359

8.  Factors that influence blood loss and need for transfusion following total knee arthroplasty.

Authors:  Achilleas Boutsiadis; Ryan Jacob Reynolds; Mo Saffarini; Jean-Claude Panisset
Journal:  Ann Transl Med       Date:  2017-11

9.  Efficacy and Safety of 3 Different Anesthesia Techniques Used in Total Hip Arthroplasty.

Authors:  Chengwei Liang; Jionglin Wei; Xiaoxi Cai; Weilong Lin; Yongqian Fan; Fengjian Yang
Journal:  Med Sci Monit       Date:  2017-08-02

10.  Rivaroxaban improves hidden blood loss, blood transfusion rate and reduces swelling of the knee joint in knee osteoarthritis patients after total knee replacement.

Authors:  Yi-Min Zhang; Jian-Yong Liu; Xue-Dong Sun; Miao Zhang; Xiao-Guang Liu; Xiu-Li Chen
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.